Online Only Articles

Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes

Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain
Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain
Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy;Laboratory of Neuro-Oncohematology, Santa Lucia Foundation, Rome, Italy
Laboratorios Dr. Moreira, Monterrey, Mexico
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy
Medical Sciences Department, Faculty of Medicine/University of Ciudad Real (UCLM), Spain
Maimónides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba/Reina Sofia University Hospital, Spain
Maimónides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba/Reina Sofia University Hospital, Spain
Hematology Department University Hospital Morales Meseguer-IMIB, Spain
Hematology Department University Hospital Morales Meseguer-IMIB, Spain
Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain
Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain
Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain
Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain
Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain
Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain
Department of Biomedicine and Prevention, “Tor Vergata” University, Rome, Italy;Laboratory of Neuro-Oncohematology, Santa Lucia Foundation, Rome, Italy
Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain
Vol. 103 No. 9 (2018): September, 2018 https://doi.org/10.3324/haematol.2018.188433